Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Svetofor Group recommended that dividends be paid for 2023

5/27/24 SVET

TGC-14 reported for 3 months of 2024 by RAS

5/27/24 TGKN

Board of Directors of Novorossiysk Commercial Sea Port recommended that dividends be paid for 2023

5/27/24 NMTP

VKontakte became the most popular platform for blogs

5/27/24 VKCO

Shareholders of ICAO Headhunter completed the additional share issue for the exchange of HeadHunter receipts

5/27/24 HEAD

MTS extended its offer to buy back shares from non-residents

5/27/24 MTSS

Board of Directors of EvroTrans recommended that dividends be paid for 3 months 2024

5/27/24 EUTR

Board of Directors of EvroTrans recommended that dividends be paid for 2023

5/27/24 EUTR

Board of Directors of INARCTICA recommended that dividends be paid for 3 months 2024

5/27/24 AQUA

Shareholders of TGC-14 approved dividends for 2023

5/27/24 TGKN